|
市場調査レポート
商品コード
1373873
乳がんの世界市場の規模、シェア、成長分析：がん別、流通チャネル別 - 産業予測（2023年～2030年）Global Breast Cancer Market Size, Share, Growth Analysis, By Cancer(Hormone Receptor-positive (HR+) and HER2-positive (HER2+)), By Distribution Channel(hospital pharmacies, retail pharmacies) - Industry Forecast 2023-2030 |
||||||
|
|
|||||||
| 乳がんの世界市場の規模、シェア、成長分析：がん別、流通チャネル別 - 産業予測（2023年～2030年） |
|
出版日: 2023年10月12日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
世界の乳がんの市場規模は、2021年に288億8,000万米ドルとなり、2022年の318億9,000万米ドルから2030年までに705億3,000万米ドルに達し、予測期間（2023年～2030年）にCAGRで10.43%の成長が見込まれています。
市場は、世界の乳がん罹患率の増加によって牽引されています。ライフスタイルの変化、ホルモンバランスの乱れ、遺伝的素因、高齢化などの要因が、乳がん患者の増加に寄与しています。このような患者数の増加により、効果的で革新的な治療オプションや診断ツールの開発が必要とされています。技術の進歩は市場の成長において重要な役割を果たしています。分子イメージング、遺伝子検査、リキッドバイオプシーなどの新しい診断技術は、乳がんの早期発見と正確な診断を可能にします。同様に、標的療法、免疫療法、精密医療を含む治療法の進歩は、患者の転帰と生存率を向上させています。これらの進歩は、市場における革新的な製品や治療法に対する需要を促進しています。さらに、一般市民の乳がんと早期発見の重要性に対する意識の高まりにより、検診プログラムや定期検診への参加が増加しています。世界中の政府や医療機関が早期発見を促進する啓発キャンペーンを実施しており、その結果、検診や診断の需要が増加しています。成長見通しにもかかわらず、市場はいくつかの課題にも直面しています。重要な課題の1つは、手術、化学療法、放射線療法、標的療法などの乳がん治療に伴う高いコストです。患者や医療システムにかかる経済的負担は、特にリソースに制約のある環境では、最適な治療オプションへのアクセスを制限する可能性があります。
世界の乳がんの市場力学
世界の乳がん市場の促進要因
意識の高まりと早期発見
乳がんと早期発見の重要性に対する意識の高まりにより、検診プログラムや定期検診への参加が増加しています。政府の取り組みや、意識向上キャンペーン、支援組織が早期発見の促進に重要な役割を果たしており、市場の成長に寄与しています。
医療支出の増加
先進国を中心とした医療支出の増加が市場の成長を支えています。研究開発、インフラ開発、先進の治療法へのアクセスへの投資が、市場にプラスの影響を与えています。
世界の乳がん市場における抑制要因
個別化医療における課題
乳がんは不均一な疾患であり、さまざまな亜型や治療反応のばらつきがあります。個別化された治療アプローチを開発し、各患者に最適な治療法を特定することは困難で時間がかかるため、精密医療の普及が制限されています。
医療格差と治療へのアクセス
医療へのアクセスにおける格差、特に低所得地域や十分なサービスを受けていない人々における格差が大きな障害となっています。検診プログラム、診断施設、専門的治療、支持療法サービスへのアクセスが限られているため、タイムリーな診断と最適な治療が妨げられ、市場成長に影響を与えています。
世界の乳がんの動向
標的療法の台頭：標的療法は、がん細胞内の特定の分子異常を選択的に標的とすることで、乳がん治療に革命をもたらしました。モノクローナル抗体やチロシンキナーゼ阻害薬などのHER2標的療法は、HER2陽性乳がんの治療成績を大幅に改善しました。さらに、PI3K阻害薬やCDK4/6阻害薬など、その他の分子標的に焦点を当てた新たな標的療法が、さまざまな乳がんの亜型で有望視されています。
患者中心のアプローチ：市場では患者中心の治療が重視されるようになってきています。患者擁護団体、医療提供者、製薬企業が協力して、乳がん患者の全人的なニーズに対応しています。これには、ペイシェントジャーニーを通じて患者のQOLを向上させるための支持療法サービス、サバイバーシッププログラム、心理社会的サポートの提供などが含まれます。
当レポートでは、世界の乳がん市場について調査分析し、市場力学と見通し、セグメント分析、企業プロファイルなどを提供しています。
目次
エグゼクティブサマリー
調査手法
親市場の分析
主な市場の考察
- 技術分析
- 価格分析
- サプライチェーン分析
- バリューチェーン分析
- 市場のエコシステム
- IP分析
- 貿易分析
- スタートアップ分析
- 原材料の分析
- イノベーションマトリクス
- パイプライン製品の分析
- マクロ経済指標
- 主な投資の分析
- 主な成功要因
- 競合の程度
市場力学と見通し
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 規制情勢
- ポーターの分析
- 将来の混乱についての特別な考察
世界の乳がん市場：がん別
- 市場の概要
- ホルモン受容体陽性（HR+）
- HER2陽性（HER2+）
世界の乳がん市場：流通チャネル別
- 市場の概要
- 病院薬局
- 小売薬局
- オンライン薬局
- その他のチャネル
世界の乳がんの市場規模：地域別
- 市場の概要
- 北米
- 米国
- カナダ
- 欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他の欧州
- アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他のアジア太平洋
- ラテンアメリカ
- ブラジル
- その他のラテンアメリカ
- 中東・アフリカ
- GCC諸国
- 南アフリカ
- その他の中東・アフリカ
競合情勢
- 上位5社の比較
- 主要企業の市場ポジショニング（2021年）
- 主な市場企業が採用した戦略
- 主要成功戦略
- 市場における最近の活動
- 主要企業の市場シェア（2021年）
主要企業プロファイル
- Pfizer Inc. - US
- Novartis AG - Switzerland
- Roche Holding AG - Switzerland
- AstraZeneca PLC - UK
- Johnson & Johnson - US
- Merck & Co., Inc. - US
- Bristol Myers Squibb Company - US
- Eli Lilly and Company - US
- Sanofi - France
- AbbVie Inc. - US
- Daiichi Sankyo Company, Limited - Japan
- Amgen Inc. - US
- Genentech, Inc. - US
- Takeda Pharmaceutical Company Limited - Japan
- Eisai Co., Ltd. - Japan
- Mylan N.V. - US
- Celgene Corporation - US
- Astellas Pharma Inc. - Japan
- Teva Pharmaceutical Industries Ltd. - Israel
- Hologic, Inc. - US
Global Breast Cancer Market size was valued at USD 28.88 Billion in 2021 and is poised to grow from USD 31.89 Billion in 2022 to USD 70.53 Billion by 2030, at a CAGR of 10.43% during the forecast period (2023-2030).
The breast cancer market is driven by the increasing incidence of breast cancer cases globally. Factors such as lifestyle changes, hormonal imbalances, genetic predisposition, and the aging population contribute to the rising number of breast cancer cases. This growing patient population necessitates the development of effective and innovative treatment options and diagnostic tools. Technological advancements play a crucial role in the growth of the breast cancer market. Novel diagnostic techniques, such as molecular imaging, genetic testing, and liquid biopsies, enable early detection and accurate diagnosis of breast cancer. Similarly, advancements in treatment modalities, including targeted therapies, immunotherapies, and precision medicine, have improved patient outcomes and survival rates. These advancements drive the demand for innovative products and therapies in the market. Moreover, the increasing awareness of breast cancer and the importance of early detection among the general population have led to greater participation in screening programs and routine check-ups. Governments and healthcare organizations worldwide have implemented awareness campaigns to promote early detection, resulting in increased demand for screening and diagnostic procedures. Despite the growth prospects, the breast cancer market also faces several challenges. One significant challenge is the high cost associated with breast cancer treatment, including surgery, chemotherapy, radiation therapy, and targeted therapies. The financial burden on patients and healthcare systems can limit access to optimal treatment options, especially in resource-constrained settings.
Top-down and bottom-up approaches were used to estimate and validate the size of the global Breast Cancer Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Breast Cancer Market Segmental Analysis
The global breast cancer market is segmented on the basis of cancer, distribution channel, and region. By cancer, the market is segmented into Hormone Receptor-positive (HR+) and HER2-positive (HER2+) breast cancer. By distribution, the market is segmented into hospital pharmacies, retail pharmacies, online pharmacies, and other channels. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Global Breast Cancer Market Dynamics
Drivers of the Global Breast Cancer Market
Growing Awareness and Early Detection
Increased awareness about breast cancer and the importance of early detection have led to higher participation in screening programs and routine check-ups. Government initiatives, awareness campaigns, and advocacy organizations have played a significant role in promoting early detection, contributing to market growth.
Rising Healthcare Expenditure
Increased healthcare spending, particularly in developed economies, has supported the growth of the breast cancer market. Investments in research and development, infrastructure development, and access to advanced treatment modalities have positively impacted the market.
Restraints in the Global Breast Cancer Market
Challenges in Personalized Medicine
Breast cancer is a heterogeneous disease, with different subtypes and variations in treatment response. Developing personalized treatment approaches and identifying the most suitable therapies for each patient can be challenging and time-consuming, limiting widespread adoption of precision medicine.
Healthcare Inequalities and Access to Care
Disparities in healthcare access, particularly in low-income regions and underserved populations, pose a significant restraint. Limited access to screening programs, diagnostic facilities, specialized treatments, and supportive care services can hinder timely diagnosis and optimal treatment, impacting market growth.
Market Trends of the Global Breast Cancer Key
Rise of Targeted Therapies: Targeted therapies have revolutionized breast cancer treatment by selectively targeting specific molecular abnormalities in cancer cells. HER2-targeted therapies, such as monoclonal antibodies and tyrosine kinase inhibitors, have significantly improved outcomes in HER2-positive breast cancer. Additionally, emerging targeted therapies that focus on other molecular targets, such as PI3K inhibitors and CDK4/6 inhibitors, are showing promise in various breast cancer subtypes.
Patient-Centric Approaches: There is a growing emphasis on patient-centered care in the breast cancer market. Patient advocacy groups, healthcare providers, and pharmaceutical companies are working together to address the holistic needs of breast cancer patients. This includes providing supportive care services, survivorship programs, and psychosocial support to improve the quality of life for patients throughout their journey.
Table of Contents
- Executive Summary
- Market Overview
- Wheel of Fortune
- Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
- Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
- Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
- Global Breast Cancer Market by Cancer
- Market Overview
- Hormone Receptor-positive (HR+) and HER2-positive (HER2+)
- Global Breast Cancer Market by Distribution Channel
- Market Overview
- hospital pharmacies
- retail pharmacies
- online pharmacies
- and other channels
- Global Breast Cancer Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
- Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
- Key Company Profiles
- Pfizer Inc. - US
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Novartis AG - Switzerland
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Roche Holding AG - Switzerland
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- AstraZeneca PLC - UK
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Johnson & Johnson - US
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Merck & Co., Inc. - US
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bristol Myers Squibb Company - US
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Eli Lilly and Company - US
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sanofi - France
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- AbbVie Inc. - US
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Daiichi Sankyo Company, Limited - Japan
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Amgen Inc. - US
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Genentech, Inc. - US
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Takeda Pharmaceutical Company Limited - Japan
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Eisai Co., Ltd. - Japan
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Mylan N.V. - US
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Celgene Corporation - US
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Astellas Pharma Inc. - Japan
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Teva Pharmaceutical Industries Ltd. - Israel
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Hologic, Inc. - US
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
